SlideShare ist ein Scribd-Unternehmen logo
1 von 7
Downloaden Sie, um offline zu lesen
application note
Our Tips for Viscous Sample Introduction
Following these simple guidelines will get you the best
data for viscous samples:
Flushing — The most important thing when it comes
to viscous samples is to equilibrate your flow cell.
Not doing it properly can lead to the formation of
Schlieren lines which can cause issues with particle
count and morphology. Flush the flow cell either with
the sample itself or a buffer with similar optical and
physical properties until no Schlieren lines (Figure 1)
appear along the edge of the flow cell. The volume
needed mainly depends on your solution’s viscosity,
and for very viscous samples you’ll need higher flush
volumes to equilibrate. We chose 5 mL of flush volume
for our experiments here because it worked for all our
conditions. But you can often go lower for less viscous
samples.
Mixing — Mix your samples really well. A homogenous
sample is crucial for accurate sample characterization.
Easy Particle Analysis for Viscous Samples with MFI
Introduction
Many protein therapeutics in development today are viscous because
they contain excipients for stability or have a high concentration
of the protein itself. If you use particle analysis techniques like light
obscuration, the only way to analyze these samples accurately is to
dilute them. But dilution can change the characteristics of the sample,
which means more comparability studies to validate the dilution
effect. Why make your work harder? MFI lets you skip the whole
dilution process.
We studied the MFI 5200 manual system performance across a broad
range of sample viscosities and you guessed it — we got precise
and quantitative characterization of particle size, concentration, and
morphology with even the most viscous solutions. And while the data
in this application note is from the MFI 5200 system, we also looked at
the MFI 5100 system and saw the same great results: robust particle
measurement using neat samples. So if you want out of the dilution
boat, read on!
Avoid air bubbles — Air bubbles are more easily trapped
in viscous solutions than in aqueous ones. You can avoid
introducing them by gently mixing your samples using
end-over-end rotation. Avoid the forceful agitation route.
Pump Calibration — For sample viscosities up to 20 cP,
standard water calibration is fine, so you don’t have to
worry about recalibrating your pump.
Morphology — In our study, viscosity didn’t have a
strong effect on the data. But, if the viscosity of your
sample comes from a matrix with a significantly different
refractive index, you may see stronger effects.1
If that’s the
case, your best bet is to characterize NIST sizing beads
in your matrix to see if the sample’s refractive index is
impacted by solution viscosity.
application note
2
Easy Particle Analysis for Viscous Samples with MFI
For our study, we compared particle characterization
in viscous solutions to water on the MFI 5200 system.
The parameters we evaluated included sample volume
analyzed, particle count and particle size. We also looked
at important morphological parameters to confirm our
measurements weren’t affected by sample viscosity.
How We Analyzed Samples
For particle count and size, the analysis workflow
(Figure 2) and the Analysis Method (Figure 3) used
were the same. The only difference in the Analysis
Method was the application of Edge Particle Rejection.
For the counting analysis Edge Particle Rejection was
turned off, and for the sizing analysis it was turned on.
This allowed us to more accurately determine size and
count. All samples were introduced to the MFI 5200
system using a syringe barrel and analyzed in triplicate.
SAMPLE VOLUME ANALYSIS
We made samples with viscosities ranging from
1 centipoise (cP) to 20 cP using a series of polyethylene-
glycol (PEG) dilutions, then confirmed solution viscosity
using a Rheosense Inc. uVisc. Syringe Viscometer.
Viscous samples can be less mobile in the fluid path, so
we wanted to find out if this was a potential problem
area for the analysis volume. Before each sample was
analyzed, the MFI 5200 system was primed with the
appropriate PEG solution, and the method was set to
analyze 900 µL with 220 µL for optimize illumination and
no flush. We then recovered the analyzed volume from
the waste line with a pre-weighed Eppendorf tube. As
shown in Figure 4, the analyzed sample volumes were
consistent, regardless of sample viscosity. Because it
uses a slow analysis speed, the MFI flow cell precisely
analyzed the same amount of sample no matter if it
Figure 1.	 Schlieren line in priming view. Particles coincident with the Schlieren line are interpreted
as a single massive particle by the software.
Figure 2.	 Workflow used to analyze viscous samples.
Schlieren line
Remove syringe
barrel from
instrument and
wash with 20 mL of
particle-free water.
Reattach syringe
barrel and wash
flow cell with 10 mL
particle-free water.
Begin sample
analysis.
Flush 5 mL of
sample through
flow cell to get rid
of Schlieren lines.
Carefully load
sample into syringe
barrel. Take care to
minimize bubbles.
application note
3
Easy Particle Analysis for Viscous Samples with MFI
was an aqueous solution or a viscous (PEG) one. This
also means there isn’t any need to recalibrate the pump,
which is time saved during setup. How nice is that?
We all know the MFI 5200 system accurately and
precisely characterizes particles in the sub-visible range
(2 – 25 microns). So the next thing we looked at is how well it
stacked up with counting particles in viscous samples.
Same Great Data for Particle Size and
Concentration
For our concentration evaluation, NIST-certified 5 µm,
10 µm and 25 µm COUNT-CAL standards (ProteinSimple)
were mixed at a 1:1 ratio with the PEG solutions so the
final viscosities of the solutions would be at the intended
cP range. We confirmed viscosity with the viscometer,
Figure 3.	 Method used for sample analysis. The Total Available Volume was set to 0.90 mL, which translates to
an analyzed volume of 0.77 mL.
Figure 4.	 Sample analysis volumes are consistent across a range of viscosities. For all tested
samples, values for the analysis were within 5% of the nominal 900 µL, showing that even high
viscosity samples can be precisely measured through the flow cell. This precision over a wide
range of viscosities is key to accurately determining particle concentration.
10
800
820
840
860
880
900
920
940
960
980
1000
20 15 5 Water
VolumeRecovered(µL)
Viscosity (cP)
Analysis Volume at Different Viscosities
application note
4
Easy Particle Analysis for Viscous Samples with MFI
The Duke Size Standard analysis also showed viscosity
had no effect on data quality. Bead standards at all
viscosities were measured to within 5% of their expected
values (Figure 6), confirming that viscosity doesn’t impact
particle size measurements. So that means you’ll get
accurate sizing information with samples up to 20 cP. And,
replicates for each sample were super tight— variability
in the ECD measurements were <1% for the sample in
triplicate (Figure 6).
So What About Morphology?
Because we know it’ll help you identify the morphology
of your particles, we also analyzed common parameters
on top of the size and count metrics the standards are
designed to represent (Figure 7, 8, 9, 10). While the
data didn’t show strong differences in characterization
and then mixed samples by rotating end over end for
20 minutes before analysis.
Data for the COUNT-CAL bead analysis showed that you
can accurately determine particle concentration even
with samples as viscous as 20 cP (Figure 5). We analyzed
data with MVSS 4.0 using standard NIST filters (Table 1).
COUNT-CAL beads have a published concentration of
3000 particles per mL at their stock concentration, with
a variability of +/- 10%. After we diluted the bead stocks
1:1 with a PEG solution, the nominal concentration was
1500 particles per mL. Each condition was measured in
triplicate. The recovered concentrations for samples fell
within 90 – 110% of the expected 1500 particles/mL, and
CVs for the triplicate measurements were below 6%, right
within spec.
Figure 5.	 Recovered concentrations for samples over a range of
viscosities. Error bars represent standard deviations.
BEAD SIZE PARAMETER FILTER
5 µm ECD >3.0 µm
10 µm ECD >7.5 µm
25 µm ECD >15 µm
5 µm
10 µm
25 µm
Concentration(Particles/mL)
0
200
400
600
800
1000
1200
1400
1600
1800
2000
1 5 10 15 20
Concentration of COUNT-CAL Beads in Viscous Matrix
Viscosity (cP)
1 5 10 15 20
%ofNominalDiameter
Viscosity (cP)
Duke Sizing Standards Analyzed in Viscous Matrix
2 µm
5 µm
10 µm
25 µm
85
90
95
100
105
110
Figure 6.	 Size measurements from 1 – 20 cP. Bead standards were all
within 5% of the expected values. CVs for the triplicate measurements
were <1%.
Table 1.	 Standard NIST filters used to categorize
results.
application note
5
Easy Particle Analysis for Viscous Samples with MFI
results, statistical analysis did reveal subtle effects that the
sample matrix had on particle characterization. We chose
the 2 µm bead set for linear regression analysis to get a
read on any significant differences between the viscosity
conditions. And it turns out that morphologic measures
Figure 7.	 Measured particle intensity max. The maximum intensity
of the all pixels representing the particle.
Figure 8.	 Measured circularity. The circumference of an equivalent
area circle divided by the actual perimeter of the particle.
aren’t adversely impacted, so no significant changes
to intensity max, circularity, and aspect ratio (Table 2,
3, 4). We noticed only a very small change in pixel area
(Table 5).
0
100
200
300
400
500
600
700
800
900
1 5 10 15 20
AverageIntensityMax
Viscosity (cP)
Particle Intensity Max
2 µm
5 µm
10 µm
25 µm
2 µm
5 µm
10 µm
25 µm
1 5 10 15 20
Viscosity (cP)
0.91
0.90
0.89
0.88
0.87
0.86
0.85
0.84Circularity
Circularity
CIRCULARITY OF 2 µm BEADS COMPARED TO 1 cP CONDITION
VISCOSITY COEFFICIENTS STANDARD ERROR P-VALUE
Intercept 0.86 0.0003 2.35E-132
5 cP -0.0003 0.0003 0.27
10 cP -0.0003 0.0003 0.40
15 cP -0.0006 0.0003 0.06
20 cP -0.0003 0.0003 0.27
INTENSITY MAX OF 2µm BEADS COMPARED TO 1 cP CONDITION
VISCOSITY COEFFICIENTS STANDARD ERROR P-VALUE
Intercept 778.10 0.57 4.32E-116
5 cP -0.03 0.57 0.96
10 cP -0.01 0.57 0.99
15 cP 0.25 0.57 0.66
20 cP 0.69 0.57 0.23
Table 2.	 Particle intensity statistical analysis of 2 µm beads. Linear
regression confirmed there was no change in particle intensity max
that correlated with viscosity (Model R2
=0.999).
Table 3.	 Circularity statistical analysis of 2 µm beads. Linear
regression gave no significant difference in circularity for any of our
viscous conditions (Model R2
=0.998).
application note
6
Easy Particle Analysis for Viscous Samples with MFI
PIXEL AREA OF 2 µm BEADS COMPARED TO 1 cP CONDITION
VISCOSITY COEFFICIENTS STANDARD ERROR P-VALUE
Intercept 24.28 0.27 2.39E-57
5 cP 0.64 0.27 1.89E-02
10 cP 1.07 0.27 1.83E-04
15 cP 1.22 0.27 2.89E-05
20 cP 0.94 0.27 9.12E-04
But it gets even better! There were no adverse impacts
on morphologic parameters, and no significant changes
to aspect ratio, intensity max, or circularity — and only
a change of one pixel in particle area. Translation? In
a nutshell, you can run your viscous samples straight
up with MFI and still get precise and accurate particle
characterization.
Conclusion
MFI generates absolutely great data, even when sample
viscosity is as high as 20 cP. Now you can get the hands-
down most consistent measurement of count, size and
morphology without having to dilute a single sample!
Our analysis of NIST-certified COUNT-CAL concentration
standards from 5 to 25 microns in size proved we could
accurately determine particle concentrations to within
10% of the nominal value in viscosities ranging from
1 to 20 cP. And sizing data for NIST-certified Duke size
standards from 2 to 25 microns was within 5% of the
nominal value.
Table 4.	 Aspect ratio statistical analysis of 2 µm beads. Linear
regression showed a very small change in aspect ratio in viscous
conditions. This difference, though consistent, is less than a 1%
change in aspect ratio (Model R2
=0.997).
ASPECT RATIO OF 2 µm BEADS COMPARED TO 1 cP CONDITION
VISCOSITY COEFFICIENTS STANDARD ERROR P-VALUE
Intercept 0.8989 0.00036 3.93E-129
5 cP -0.0012 0.00036 2.07E-03
10 cP -0.0010 0.00036 7.53E-03
15 cP -0.0017 0.00036 2.52E-05
20 cP -0.0014 0.00036 2.48E-04
Table 5.	 Pixel area statistical analysis of 2 µm beads. Linear
regression showed a small but consistent increase in the pixel area
under viscous conditions. But we know from the calculated values
the change wasn’t sufficient enough to impact particle sizing
(Model R2
=0.999).
Figure 9.	 Measured aspect ratio. The ratio of the minor axis length
of the major axis length of an ellipse that has the same second
moments of the particle.
Figure 10.	 Measured pixel area. The number of pixels representing a
particle.
2 µm
5 µm
10 µm
25 µm
1 5 10 15 20
Viscosity (cP)
0.96
0.95
0.94
0.93
0.92
0.91
0.90
0.89
0.88
0.87
AspectRatio
Aspect Ratio
PixelArea
Pixel Area
450
400
350
300
250
200
150
100
50
0
1 5 10 15 20
Viscosity (cP)
2 µm
5 µm
10 µm
25 µm
Toll-free: (888) 607-9692
Tel: (408) 510-5500
Fax: (408) 510-5599
orders@proteinsimple.com
proteinsimple.com
Rev B.
application note
7
Easy Particle Analysis for Viscous Samples with MFI
Toll-free: (888) 607-9692
Tel: (408) 510-5500
Fax: (408) 510-5599
info@proteinsimple.com
proteinsimple.com
©	 2015 ProteinSimple. MFI, Micro-Flow Imaging,
ProteinSimple and the ProteinSimple logo are
trademarks and/or registered trademarks of
ProteinSimple.
	 96-4004-00 / Rev A
References
1.	 How subvisible particles become invisible—relevance
of the refractive index for protein particle analysis, S
Zolls, M Gregoritza, R Tantipolphan, M Wiggenhorn, G
Winter, W Friess and A Hawe, Journal of Pharmaceutical
Sciences, 2013:102(5):1434-46.

Weitere ähnliche Inhalte

Was ist angesagt?

Introduction to Powder Size Analysis for Cell Culture Media
Introduction to Powder Size Analysis for Cell Culture MediaIntroduction to Powder Size Analysis for Cell Culture Media
Introduction to Powder Size Analysis for Cell Culture MediaKurt Sundgren
 
Analytical method Development and Validation for the estimation of Pioglitazo...
Analytical method Development and Validation for the estimation of Pioglitazo...Analytical method Development and Validation for the estimation of Pioglitazo...
Analytical method Development and Validation for the estimation of Pioglitazo...SriramNagarajan15
 
Analytical method Development and Validation for the estimation of Pioglitazo...
Analytical method Development and Validation for the estimation of Pioglitazo...Analytical method Development and Validation for the estimation of Pioglitazo...
Analytical method Development and Validation for the estimation of Pioglitazo...pharmaindexing
 
Rigaku journal xrf
Rigaku journal xrfRigaku journal xrf
Rigaku journal xrfhashimually1
 
3rd sync module 5 6
3rd sync module 5  63rd sync module 5  6
3rd sync module 5 6Hara O.
 
Module 4 isolation of chloroplasts and characterization of photosynthetic pi...
Module 4  isolation of chloroplasts and characterization of photosynthetic pi...Module 4  isolation of chloroplasts and characterization of photosynthetic pi...
Module 4 isolation of chloroplasts and characterization of photosynthetic pi...Hara O.
 
MICROMERITICS & ITS APPLICATION IN PHARMACY
MICROMERITICS & ITS APPLICATION IN PHARMACYMICROMERITICS & ITS APPLICATION IN PHARMACY
MICROMERITICS & ITS APPLICATION IN PHARMACYFaizan Akram
 
Reversible Association of a Monoclonal Antibody Studied by Concentration-Grad...
Reversible Association of a Monoclonal Antibody Studied by Concentration-Grad...Reversible Association of a Monoclonal Antibody Studied by Concentration-Grad...
Reversible Association of a Monoclonal Antibody Studied by Concentration-Grad...KBI Biopharma
 
Micromeritics
MicromeriticsMicromeritics
Micromeriticsurooj001
 
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...Sagar Savale
 
Lectut btn-202-ppt-l16. recovery of dna from agarose gel
Lectut btn-202-ppt-l16. recovery of dna from agarose gelLectut btn-202-ppt-l16. recovery of dna from agarose gel
Lectut btn-202-ppt-l16. recovery of dna from agarose gelRishabh Jain
 
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...Sagar Savale
 
Physical pharmacy and drug manufacturer guestions
Physical pharmacy and drug manufacturer guestionsPhysical pharmacy and drug manufacturer guestions
Physical pharmacy and drug manufacturer guestionsMINANI Theobald
 
The MEA 2 Personal Purification System for enhanced automated protein purific...
The MEA 2 Personal Purification System for enhanced automated protein purific...The MEA 2 Personal Purification System for enhanced automated protein purific...
The MEA 2 Personal Purification System for enhanced automated protein purific...Anne Burke
 
Elution of DNA fragments from agarose gel Practical
Elution of DNA fragments from agarose gel  Practical  Elution of DNA fragments from agarose gel  Practical
Elution of DNA fragments from agarose gel Practical Sabahat Ali
 
UV Spectrophotometric Method Development And Validation For Quantitative Esti...
UV Spectrophotometric Method Development And Validation For Quantitative Esti...UV Spectrophotometric Method Development And Validation For Quantitative Esti...
UV Spectrophotometric Method Development And Validation For Quantitative Esti...Sagar Savale
 
Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...pharmaindexing
 

Was ist angesagt? (20)

Introduction to Powder Size Analysis for Cell Culture Media
Introduction to Powder Size Analysis for Cell Culture MediaIntroduction to Powder Size Analysis for Cell Culture Media
Introduction to Powder Size Analysis for Cell Culture Media
 
Analytical method Development and Validation for the estimation of Pioglitazo...
Analytical method Development and Validation for the estimation of Pioglitazo...Analytical method Development and Validation for the estimation of Pioglitazo...
Analytical method Development and Validation for the estimation of Pioglitazo...
 
Analytical method Development and Validation for the estimation of Pioglitazo...
Analytical method Development and Validation for the estimation of Pioglitazo...Analytical method Development and Validation for the estimation of Pioglitazo...
Analytical method Development and Validation for the estimation of Pioglitazo...
 
Rigaku journal xrf
Rigaku journal xrfRigaku journal xrf
Rigaku journal xrf
 
3rd sync module 5 6
3rd sync module 5  63rd sync module 5  6
3rd sync module 5 6
 
Module 4 isolation of chloroplasts and characterization of photosynthetic pi...
Module 4  isolation of chloroplasts and characterization of photosynthetic pi...Module 4  isolation of chloroplasts and characterization of photosynthetic pi...
Module 4 isolation of chloroplasts and characterization of photosynthetic pi...
 
Micromeritics
MicromeriticsMicromeritics
Micromeritics
 
MICROMERITICS & ITS APPLICATION IN PHARMACY
MICROMERITICS & ITS APPLICATION IN PHARMACYMICROMERITICS & ITS APPLICATION IN PHARMACY
MICROMERITICS & ITS APPLICATION IN PHARMACY
 
Reversible Association of a Monoclonal Antibody Studied by Concentration-Grad...
Reversible Association of a Monoclonal Antibody Studied by Concentration-Grad...Reversible Association of a Monoclonal Antibody Studied by Concentration-Grad...
Reversible Association of a Monoclonal Antibody Studied by Concentration-Grad...
 
Gpc
GpcGpc
Gpc
 
Micromeretis
Micromeretis Micromeretis
Micromeretis
 
Micromeritics
MicromeriticsMicromeritics
Micromeritics
 
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
 
Lectut btn-202-ppt-l16. recovery of dna from agarose gel
Lectut btn-202-ppt-l16. recovery of dna from agarose gelLectut btn-202-ppt-l16. recovery of dna from agarose gel
Lectut btn-202-ppt-l16. recovery of dna from agarose gel
 
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
 
Physical pharmacy and drug manufacturer guestions
Physical pharmacy and drug manufacturer guestionsPhysical pharmacy and drug manufacturer guestions
Physical pharmacy and drug manufacturer guestions
 
The MEA 2 Personal Purification System for enhanced automated protein purific...
The MEA 2 Personal Purification System for enhanced automated protein purific...The MEA 2 Personal Purification System for enhanced automated protein purific...
The MEA 2 Personal Purification System for enhanced automated protein purific...
 
Elution of DNA fragments from agarose gel Practical
Elution of DNA fragments from agarose gel  Practical  Elution of DNA fragments from agarose gel  Practical
Elution of DNA fragments from agarose gel Practical
 
UV Spectrophotometric Method Development And Validation For Quantitative Esti...
UV Spectrophotometric Method Development And Validation For Quantitative Esti...UV Spectrophotometric Method Development And Validation For Quantitative Esti...
UV Spectrophotometric Method Development And Validation For Quantitative Esti...
 
Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...
 

Andere mochten auch (10)

Codigo%20 conduta%20%c3%89tica%20u minho
Codigo%20 conduta%20%c3%89tica%20u minhoCodigo%20 conduta%20%c3%89tica%20u minho
Codigo%20 conduta%20%c3%89tica%20u minho
 
Medida provisoria (1)
Medida provisoria (1)Medida provisoria (1)
Medida provisoria (1)
 
Question 2.
Question 2.Question 2.
Question 2.
 
Why are there so few women in power
Why are there so few women in powerWhy are there so few women in power
Why are there so few women in power
 
Housing and Health: making the case for a public health approach
Housing and Health: making the case for a public health approachHousing and Health: making the case for a public health approach
Housing and Health: making the case for a public health approach
 
Programme d'investissement d'avenir consacré à l'économie sociale et solidaire
Programme d'investissement d'avenir consacré à l'économie sociale et solidaireProgramme d'investissement d'avenir consacré à l'économie sociale et solidaire
Programme d'investissement d'avenir consacré à l'économie sociale et solidaire
 
les limites de l’économie sociale et solidaire
les limites de l’économie sociale et solidaireles limites de l’économie sociale et solidaire
les limites de l’économie sociale et solidaire
 
doku.pdf
doku.pdfdoku.pdf
doku.pdf
 
PI-041_Arbeitsmarktreport.pdf
PI-041_Arbeitsmarktreport.pdfPI-041_Arbeitsmarktreport.pdf
PI-041_Arbeitsmarktreport.pdf
 
NTC
NTCNTC
NTC
 

Ähnlich wie Viscous Sample Analysis with MFI

Particle size distribution and its methods
Particle size distribution and its methodsParticle size distribution and its methods
Particle size distribution and its methodssony mohammed
 
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulationsSucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulationsMilliporeSigma
 
Final submission –Pay attention to APA formatting, spelling, and
Final submission –Pay attention to APA formatting, spelling, andFinal submission –Pay attention to APA formatting, spelling, and
Final submission –Pay attention to APA formatting, spelling, andChereCheek752
 
SURE Research Report v1
SURE Research Report v1SURE Research Report v1
SURE Research Report v1Dana Joaquin
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...KBI Biopharma
 
Quality control of oral liquid dosage form .pdf
Quality control of oral liquid dosage form .pdfQuality control of oral liquid dosage form .pdf
Quality control of oral liquid dosage form .pdfUVAS
 
Pipette Calibration Worksheet & Guidelines -M. Asif
Pipette Calibration Worksheet & Guidelines -M. AsifPipette Calibration Worksheet & Guidelines -M. Asif
Pipette Calibration Worksheet & Guidelines -M. AsifRana Muhammad Asif
 
Automated SPE for Capillary Microsampling Poster
Automated SPE for Capillary Microsampling PosterAutomated SPE for Capillary Microsampling Poster
Automated SPE for Capillary Microsampling PosterRick Youngblood
 
Micro
MicroMicro
MicroPSI
 
Improved coverage of the proteome using gel eluted liquid
Improved coverage of the proteome using gel eluted liquidImproved coverage of the proteome using gel eluted liquid
Improved coverage of the proteome using gel eluted liquidExpedeon
 
Lab1 spectrophotometry
Lab1 spectrophotometryLab1 spectrophotometry
Lab1 spectrophotometryCody Taylor
 
Validation for immunoassay
Validation for immunoassayValidation for immunoassay
Validation for immunoassayDHINESHKUMAR V
 
Medimmune_022108
Medimmune_022108Medimmune_022108
Medimmune_022108WISBIOMED
 
Jie Zheng at #ICG12: PhenoSpD: an atlas of phenotypic correlations and a mult...
Jie Zheng at #ICG12: PhenoSpD: an atlas of phenotypic correlations and a mult...Jie Zheng at #ICG12: PhenoSpD: an atlas of phenotypic correlations and a mult...
Jie Zheng at #ICG12: PhenoSpD: an atlas of phenotypic correlations and a mult...GigaScience, BGI Hong Kong
 
aseptic process technology
 aseptic process technology aseptic process technology
aseptic process technologyPRANJAY PATIL
 
ICSA17 - Bula Dosagem Proteínas
 ICSA17 - Bula Dosagem Proteínas ICSA17 - Bula Dosagem Proteínas
ICSA17 - Bula Dosagem ProteínasRicardo Portela
 
Practical 3 Quantitative determination of protein concentration using spectro...
Practical 3 Quantitative determination of protein concentration using spectro...Practical 3 Quantitative determination of protein concentration using spectro...
Practical 3 Quantitative determination of protein concentration using spectro...mohamedseyam13
 

Ähnlich wie Viscous Sample Analysis with MFI (20)

Particle size distribution and its methods
Particle size distribution and its methodsParticle size distribution and its methods
Particle size distribution and its methods
 
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulationsSucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
 
Final submission –Pay attention to APA formatting, spelling, and
Final submission –Pay attention to APA formatting, spelling, andFinal submission –Pay attention to APA formatting, spelling, and
Final submission –Pay attention to APA formatting, spelling, and
 
SURE Research Report v1
SURE Research Report v1SURE Research Report v1
SURE Research Report v1
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
 
Quality control of oral liquid dosage form .pdf
Quality control of oral liquid dosage form .pdfQuality control of oral liquid dosage form .pdf
Quality control of oral liquid dosage form .pdf
 
Pipette Calibration Worksheet & Guidelines -M. Asif
Pipette Calibration Worksheet & Guidelines -M. AsifPipette Calibration Worksheet & Guidelines -M. Asif
Pipette Calibration Worksheet & Guidelines -M. Asif
 
Automated SPE for Capillary Microsampling Poster
Automated SPE for Capillary Microsampling PosterAutomated SPE for Capillary Microsampling Poster
Automated SPE for Capillary Microsampling Poster
 
Micro
MicroMicro
Micro
 
Micromeritics
MicromeriticsMicromeritics
Micromeritics
 
Improved coverage of the proteome using gel eluted liquid
Improved coverage of the proteome using gel eluted liquidImproved coverage of the proteome using gel eluted liquid
Improved coverage of the proteome using gel eluted liquid
 
Lab1 spectrophotometry
Lab1 spectrophotometryLab1 spectrophotometry
Lab1 spectrophotometry
 
Validation for immunoassay
Validation for immunoassayValidation for immunoassay
Validation for immunoassay
 
Medimmune_022108
Medimmune_022108Medimmune_022108
Medimmune_022108
 
Jie Zheng at #ICG12: PhenoSpD: an atlas of phenotypic correlations and a mult...
Jie Zheng at #ICG12: PhenoSpD: an atlas of phenotypic correlations and a mult...Jie Zheng at #ICG12: PhenoSpD: an atlas of phenotypic correlations and a mult...
Jie Zheng at #ICG12: PhenoSpD: an atlas of phenotypic correlations and a mult...
 
PURE_Poster
PURE_PosterPURE_Poster
PURE_Poster
 
E5 protein
E5 proteinE5 protein
E5 protein
 
aseptic process technology
 aseptic process technology aseptic process technology
aseptic process technology
 
ICSA17 - Bula Dosagem Proteínas
 ICSA17 - Bula Dosagem Proteínas ICSA17 - Bula Dosagem Proteínas
ICSA17 - Bula Dosagem Proteínas
 
Practical 3 Quantitative determination of protein concentration using spectro...
Practical 3 Quantitative determination of protein concentration using spectro...Practical 3 Quantitative determination of protein concentration using spectro...
Practical 3 Quantitative determination of protein concentration using spectro...
 

Viscous Sample Analysis with MFI

  • 1. application note Our Tips for Viscous Sample Introduction Following these simple guidelines will get you the best data for viscous samples: Flushing — The most important thing when it comes to viscous samples is to equilibrate your flow cell. Not doing it properly can lead to the formation of Schlieren lines which can cause issues with particle count and morphology. Flush the flow cell either with the sample itself or a buffer with similar optical and physical properties until no Schlieren lines (Figure 1) appear along the edge of the flow cell. The volume needed mainly depends on your solution’s viscosity, and for very viscous samples you’ll need higher flush volumes to equilibrate. We chose 5 mL of flush volume for our experiments here because it worked for all our conditions. But you can often go lower for less viscous samples. Mixing — Mix your samples really well. A homogenous sample is crucial for accurate sample characterization. Easy Particle Analysis for Viscous Samples with MFI Introduction Many protein therapeutics in development today are viscous because they contain excipients for stability or have a high concentration of the protein itself. If you use particle analysis techniques like light obscuration, the only way to analyze these samples accurately is to dilute them. But dilution can change the characteristics of the sample, which means more comparability studies to validate the dilution effect. Why make your work harder? MFI lets you skip the whole dilution process. We studied the MFI 5200 manual system performance across a broad range of sample viscosities and you guessed it — we got precise and quantitative characterization of particle size, concentration, and morphology with even the most viscous solutions. And while the data in this application note is from the MFI 5200 system, we also looked at the MFI 5100 system and saw the same great results: robust particle measurement using neat samples. So if you want out of the dilution boat, read on! Avoid air bubbles — Air bubbles are more easily trapped in viscous solutions than in aqueous ones. You can avoid introducing them by gently mixing your samples using end-over-end rotation. Avoid the forceful agitation route. Pump Calibration — For sample viscosities up to 20 cP, standard water calibration is fine, so you don’t have to worry about recalibrating your pump. Morphology — In our study, viscosity didn’t have a strong effect on the data. But, if the viscosity of your sample comes from a matrix with a significantly different refractive index, you may see stronger effects.1 If that’s the case, your best bet is to characterize NIST sizing beads in your matrix to see if the sample’s refractive index is impacted by solution viscosity.
  • 2. application note 2 Easy Particle Analysis for Viscous Samples with MFI For our study, we compared particle characterization in viscous solutions to water on the MFI 5200 system. The parameters we evaluated included sample volume analyzed, particle count and particle size. We also looked at important morphological parameters to confirm our measurements weren’t affected by sample viscosity. How We Analyzed Samples For particle count and size, the analysis workflow (Figure 2) and the Analysis Method (Figure 3) used were the same. The only difference in the Analysis Method was the application of Edge Particle Rejection. For the counting analysis Edge Particle Rejection was turned off, and for the sizing analysis it was turned on. This allowed us to more accurately determine size and count. All samples were introduced to the MFI 5200 system using a syringe barrel and analyzed in triplicate. SAMPLE VOLUME ANALYSIS We made samples with viscosities ranging from 1 centipoise (cP) to 20 cP using a series of polyethylene- glycol (PEG) dilutions, then confirmed solution viscosity using a Rheosense Inc. uVisc. Syringe Viscometer. Viscous samples can be less mobile in the fluid path, so we wanted to find out if this was a potential problem area for the analysis volume. Before each sample was analyzed, the MFI 5200 system was primed with the appropriate PEG solution, and the method was set to analyze 900 µL with 220 µL for optimize illumination and no flush. We then recovered the analyzed volume from the waste line with a pre-weighed Eppendorf tube. As shown in Figure 4, the analyzed sample volumes were consistent, regardless of sample viscosity. Because it uses a slow analysis speed, the MFI flow cell precisely analyzed the same amount of sample no matter if it Figure 1. Schlieren line in priming view. Particles coincident with the Schlieren line are interpreted as a single massive particle by the software. Figure 2. Workflow used to analyze viscous samples. Schlieren line Remove syringe barrel from instrument and wash with 20 mL of particle-free water. Reattach syringe barrel and wash flow cell with 10 mL particle-free water. Begin sample analysis. Flush 5 mL of sample through flow cell to get rid of Schlieren lines. Carefully load sample into syringe barrel. Take care to minimize bubbles.
  • 3. application note 3 Easy Particle Analysis for Viscous Samples with MFI was an aqueous solution or a viscous (PEG) one. This also means there isn’t any need to recalibrate the pump, which is time saved during setup. How nice is that? We all know the MFI 5200 system accurately and precisely characterizes particles in the sub-visible range (2 – 25 microns). So the next thing we looked at is how well it stacked up with counting particles in viscous samples. Same Great Data for Particle Size and Concentration For our concentration evaluation, NIST-certified 5 µm, 10 µm and 25 µm COUNT-CAL standards (ProteinSimple) were mixed at a 1:1 ratio with the PEG solutions so the final viscosities of the solutions would be at the intended cP range. We confirmed viscosity with the viscometer, Figure 3. Method used for sample analysis. The Total Available Volume was set to 0.90 mL, which translates to an analyzed volume of 0.77 mL. Figure 4. Sample analysis volumes are consistent across a range of viscosities. For all tested samples, values for the analysis were within 5% of the nominal 900 µL, showing that even high viscosity samples can be precisely measured through the flow cell. This precision over a wide range of viscosities is key to accurately determining particle concentration. 10 800 820 840 860 880 900 920 940 960 980 1000 20 15 5 Water VolumeRecovered(µL) Viscosity (cP) Analysis Volume at Different Viscosities
  • 4. application note 4 Easy Particle Analysis for Viscous Samples with MFI The Duke Size Standard analysis also showed viscosity had no effect on data quality. Bead standards at all viscosities were measured to within 5% of their expected values (Figure 6), confirming that viscosity doesn’t impact particle size measurements. So that means you’ll get accurate sizing information with samples up to 20 cP. And, replicates for each sample were super tight— variability in the ECD measurements were <1% for the sample in triplicate (Figure 6). So What About Morphology? Because we know it’ll help you identify the morphology of your particles, we also analyzed common parameters on top of the size and count metrics the standards are designed to represent (Figure 7, 8, 9, 10). While the data didn’t show strong differences in characterization and then mixed samples by rotating end over end for 20 minutes before analysis. Data for the COUNT-CAL bead analysis showed that you can accurately determine particle concentration even with samples as viscous as 20 cP (Figure 5). We analyzed data with MVSS 4.0 using standard NIST filters (Table 1). COUNT-CAL beads have a published concentration of 3000 particles per mL at their stock concentration, with a variability of +/- 10%. After we diluted the bead stocks 1:1 with a PEG solution, the nominal concentration was 1500 particles per mL. Each condition was measured in triplicate. The recovered concentrations for samples fell within 90 – 110% of the expected 1500 particles/mL, and CVs for the triplicate measurements were below 6%, right within spec. Figure 5. Recovered concentrations for samples over a range of viscosities. Error bars represent standard deviations. BEAD SIZE PARAMETER FILTER 5 µm ECD >3.0 µm 10 µm ECD >7.5 µm 25 µm ECD >15 µm 5 µm 10 µm 25 µm Concentration(Particles/mL) 0 200 400 600 800 1000 1200 1400 1600 1800 2000 1 5 10 15 20 Concentration of COUNT-CAL Beads in Viscous Matrix Viscosity (cP) 1 5 10 15 20 %ofNominalDiameter Viscosity (cP) Duke Sizing Standards Analyzed in Viscous Matrix 2 µm 5 µm 10 µm 25 µm 85 90 95 100 105 110 Figure 6. Size measurements from 1 – 20 cP. Bead standards were all within 5% of the expected values. CVs for the triplicate measurements were <1%. Table 1. Standard NIST filters used to categorize results.
  • 5. application note 5 Easy Particle Analysis for Viscous Samples with MFI results, statistical analysis did reveal subtle effects that the sample matrix had on particle characterization. We chose the 2 µm bead set for linear regression analysis to get a read on any significant differences between the viscosity conditions. And it turns out that morphologic measures Figure 7. Measured particle intensity max. The maximum intensity of the all pixels representing the particle. Figure 8. Measured circularity. The circumference of an equivalent area circle divided by the actual perimeter of the particle. aren’t adversely impacted, so no significant changes to intensity max, circularity, and aspect ratio (Table 2, 3, 4). We noticed only a very small change in pixel area (Table 5). 0 100 200 300 400 500 600 700 800 900 1 5 10 15 20 AverageIntensityMax Viscosity (cP) Particle Intensity Max 2 µm 5 µm 10 µm 25 µm 2 µm 5 µm 10 µm 25 µm 1 5 10 15 20 Viscosity (cP) 0.91 0.90 0.89 0.88 0.87 0.86 0.85 0.84Circularity Circularity CIRCULARITY OF 2 µm BEADS COMPARED TO 1 cP CONDITION VISCOSITY COEFFICIENTS STANDARD ERROR P-VALUE Intercept 0.86 0.0003 2.35E-132 5 cP -0.0003 0.0003 0.27 10 cP -0.0003 0.0003 0.40 15 cP -0.0006 0.0003 0.06 20 cP -0.0003 0.0003 0.27 INTENSITY MAX OF 2µm BEADS COMPARED TO 1 cP CONDITION VISCOSITY COEFFICIENTS STANDARD ERROR P-VALUE Intercept 778.10 0.57 4.32E-116 5 cP -0.03 0.57 0.96 10 cP -0.01 0.57 0.99 15 cP 0.25 0.57 0.66 20 cP 0.69 0.57 0.23 Table 2. Particle intensity statistical analysis of 2 µm beads. Linear regression confirmed there was no change in particle intensity max that correlated with viscosity (Model R2 =0.999). Table 3. Circularity statistical analysis of 2 µm beads. Linear regression gave no significant difference in circularity for any of our viscous conditions (Model R2 =0.998).
  • 6. application note 6 Easy Particle Analysis for Viscous Samples with MFI PIXEL AREA OF 2 µm BEADS COMPARED TO 1 cP CONDITION VISCOSITY COEFFICIENTS STANDARD ERROR P-VALUE Intercept 24.28 0.27 2.39E-57 5 cP 0.64 0.27 1.89E-02 10 cP 1.07 0.27 1.83E-04 15 cP 1.22 0.27 2.89E-05 20 cP 0.94 0.27 9.12E-04 But it gets even better! There were no adverse impacts on morphologic parameters, and no significant changes to aspect ratio, intensity max, or circularity — and only a change of one pixel in particle area. Translation? In a nutshell, you can run your viscous samples straight up with MFI and still get precise and accurate particle characterization. Conclusion MFI generates absolutely great data, even when sample viscosity is as high as 20 cP. Now you can get the hands- down most consistent measurement of count, size and morphology without having to dilute a single sample! Our analysis of NIST-certified COUNT-CAL concentration standards from 5 to 25 microns in size proved we could accurately determine particle concentrations to within 10% of the nominal value in viscosities ranging from 1 to 20 cP. And sizing data for NIST-certified Duke size standards from 2 to 25 microns was within 5% of the nominal value. Table 4. Aspect ratio statistical analysis of 2 µm beads. Linear regression showed a very small change in aspect ratio in viscous conditions. This difference, though consistent, is less than a 1% change in aspect ratio (Model R2 =0.997). ASPECT RATIO OF 2 µm BEADS COMPARED TO 1 cP CONDITION VISCOSITY COEFFICIENTS STANDARD ERROR P-VALUE Intercept 0.8989 0.00036 3.93E-129 5 cP -0.0012 0.00036 2.07E-03 10 cP -0.0010 0.00036 7.53E-03 15 cP -0.0017 0.00036 2.52E-05 20 cP -0.0014 0.00036 2.48E-04 Table 5. Pixel area statistical analysis of 2 µm beads. Linear regression showed a small but consistent increase in the pixel area under viscous conditions. But we know from the calculated values the change wasn’t sufficient enough to impact particle sizing (Model R2 =0.999). Figure 9. Measured aspect ratio. The ratio of the minor axis length of the major axis length of an ellipse that has the same second moments of the particle. Figure 10. Measured pixel area. The number of pixels representing a particle. 2 µm 5 µm 10 µm 25 µm 1 5 10 15 20 Viscosity (cP) 0.96 0.95 0.94 0.93 0.92 0.91 0.90 0.89 0.88 0.87 AspectRatio Aspect Ratio PixelArea Pixel Area 450 400 350 300 250 200 150 100 50 0 1 5 10 15 20 Viscosity (cP) 2 µm 5 µm 10 µm 25 µm
  • 7. Toll-free: (888) 607-9692 Tel: (408) 510-5500 Fax: (408) 510-5599 orders@proteinsimple.com proteinsimple.com Rev B. application note 7 Easy Particle Analysis for Viscous Samples with MFI Toll-free: (888) 607-9692 Tel: (408) 510-5500 Fax: (408) 510-5599 info@proteinsimple.com proteinsimple.com © 2015 ProteinSimple. MFI, Micro-Flow Imaging, ProteinSimple and the ProteinSimple logo are trademarks and/or registered trademarks of ProteinSimple. 96-4004-00 / Rev A References 1. How subvisible particles become invisible—relevance of the refractive index for protein particle analysis, S Zolls, M Gregoritza, R Tantipolphan, M Wiggenhorn, G Winter, W Friess and A Hawe, Journal of Pharmaceutical Sciences, 2013:102(5):1434-46.